PET TO5

Julkaisut 2013
Publications 2013

Lisätietoja julkaisusta saa klikkaamalla sen numeroa.
For full details, please click the number in front of the publication.

1 Alakurtti K et al. Rostrocaudal gradients of dopamine D2/3 receptor binding in striatal subregions measured with [(11)C]raclopride and high-resolution positron emission tomography.
2 Authors/Task Force Members et al. 2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: The Task Froce on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developedt in collaboration with the European Heart Rhythm Association (EHRA).
3 Authors/Task Force Members et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).
4 Authors/Task Force Members et al. ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD:. the Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of Diabetes (EASD).
5 Autio A et al. Nuclear imaging of inflammation: homing-associated molecules as targets.
6 Autio A et al. Preclinical evaluation of a radioiodinated fully human antibody for in vivo imaging of vascular adhesion protein-1-positive vasculature in inflammation.
7 Badeau RM et al. Systematic metabolic markers and myocardial glucose uptake in type 2 diabetic and coronary artery disease patients treated for 16 weeks with rosiglitazone, a PPAR agonist.
8 Bonnycastle LL et al. Autosomal dominant diabetes arising from a Wolfram syndrome 1 mutation .
9 Brück A et al. [11C]PIB, [18F]FDG and MR imaging in patients with mild cognitive impairment.
10 Chow BJ et al. Computed tomographic coronary angiography for patients with heart failure (CTA-HF): a randomized controlled trial (IMAGE HF Project 1-C) .
11 Edison P et al. Comparison of MRI based and PET template based approaches in the quantitative analysis of amyloid imaging with PIB-PET.
12 Edvardsen T et al. The year 2012 in the European Heart Journal-Cardiovascular Imaging: Part I.
13 Ellfolk U et al. Brain volumetric correlates of memory in early Parkinson's disease.
14 Eskola O. Fluorine and 18F-Fluorine in Radiopharmaceutical Preparation.
15 Garibotto V et al. Cholinergic activity correlates with reserve proxies in Alzheimer's disease.
16 Gould KL et al. Anatomic versus physiologic assessment of coronary artery disease: Role of coronary flow reserve, fractional flow reserve, and positron emission tomography imaging in revascularization decision-making.
17 Heinonen I et al. Bone blood flow and metabolism in humans: effect of muscular exercise and other physiological perturbations.
18 Heinonen I et al. Effect of nitric oxide synthase inhibition on the exchange of glucose and fatty acids in human skeletal muscle.
19 Heinonen I et al. Pulmonary blood flow and its distribution in highly trained endurance athletes and healthy control subjects.
20 Heinonen I et al. Inhibition of alpha-adrenergic tone disturbs the distribution of blood flow in the exercising human limb.
21 Holstila M et al. Measurement of brown adipose tissue mass using a novel dual-echo magnetic resonance imaging approach: A validation study .
22 Honka H et al. Validation of [18F]fluorodeoxyglucose and positron emission tomography (PET) for the measurement of intestinal metabolism in pigs, and evidence of intestinal insulin resistance in patients with morbid obesity.
23 Hynninen J et al. A prospective comparison of integrated FDG-PET/contrast-enhanced CT and contrast-enhanced CT for pretreatment imaging of advanced eipthelial ovarian cancer.
24 Jokinen P et al. Cognitive slowing in Parkinson's disease is related to frontostriatal dopaminergic dysfunction.
25 Joutsa J, Kaasinen V. Parkinsonin taudin impulssikontrollihäiriöt.
26 Joutsa J et al. Reduced striatal dopamine synthesis capacity is associated with symptoms of depression in patients with de novo unmedicated Parkinson's disease.
27 Kaasinen V et al. Normal dopamine transporter SPECT in neuropathologically confirmed corticobasal degeneration.
28 Kaasinen V et al. Brain glucose metabolism in neuropathologically confirmed multiple system atrophy.
29 Kalliokoski S et al. Celiac disease-specific TG2-targeted autoantibodies inhibit angiogenesis ex vivo and in vivo in mice by interfering with endothelial cell dynamics.
30 Karlsson H et al. Increased serotonin receptor 1a binding in major depressive disorder after psychotherapy, but not after SSRI pharmacotherapy, is related to improved social functioning capacity.
31 Karlsson HK et al. Obesity is associated with white matter atrophy: A combined diffusion tensor imaging and voxel-based morphometric study.
32 Karlsson L et al. Serotonin transporter in attention-deficit hyperactivity disorder--preliminary results from a positron emission tomography study.
33 Kaskinoro K. The Effects of Anesthetic Induced Loss of Consciousness on Quantitative Electroencephalogram, and Bispectral and Spectral Entropy Indices.
34 Kauhanen S et al. Positroniemissiotomografian ja magneettikuvauksen yhdistelmällä tarkkuutta onkologiseen kuvantamiseen?
35 Kemppainen NM et al. Five-year follow-up of (11)C-PIB uptake in Alzheimer's disease and MCI.
36 Kirjavainen A et al. Electrophilic addition of chlorine monofluoride for PET tracers.
37 Knuuti J, Saraste A. Combined functional and anatomical imaging for the detection and guiding the therapy of coronary artery disease .
38 Knuuti J et al. Is cardiac magnetic resonance imaging causing DNA damage?
39 Korja M et al. Apolipoprotein E, brain injury and neurodevelopmental outcome of children.
40 Koski A et al. [(18)F]-fluorodeoxyglucose positron emission tomography and computed tomography in response evaluation of oncolytic adenovirus treatments of patients with advanced cancer.
41 Kujala UM et al. Long-term leisure-time physical activity and serum metabolome.
42 Kytö V et al. The effects of gender and age on occurence of clinically suspected myocarditis in adulthood.
43 Kähkönen E et al. In Vivo imaging of prostate cancer using (68Ga)-labeled bombesin analog BAY86-7548.
44 La Gerche A et al. Cardiac imaging and stress testing asymptomatic athletes to identify those at risk of sudden cardial death.
45 Laaksonen MS et al. Regional differences in blood flow, glucose uptake and fatty acid uptake within quadriceps femoris muscle during dynamic knee-extension exercise.
46 Laurén HB et al. Status epilepticus alters neurogenesis and decreases the number of GABAergic neurons in the septal dentate gyrus of 9-day-old rats at the early phase of epileptogenesis.
47 Leinonen V et al. Positron emission tomography with [18F]flutemetamol and [11C]PiB for in vivo detection of cerebral cortical amyloid in normal pressure hydrocephalus patients.
48 Lepomäki V et al. Preterm infants' early growth and brain white matter maturation at term age.
49 Lepomäki V et al. Effect of antenatal growth on brain white matter maturation in preterm infants at term using tract-based spatial statistics.
50 Li XG et al. Translating the concept of peptide labeling with 5-deoxy-5-(18F)fluororibose into preclinical practice: 18F-labeling of Siglec-9 peptide for PET imaging of inflammation.
51 Lidell ME et al. Evidence for two types of brown adipose tissue in humans.
52 Lindroos M. On Glucose Metabolism in Patients with the m.3243A>G Mutation.
53 Mancia G et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).
54 Michelson D et al. Lack of efficacy of L-759274, a novel neurokinin 1 (substance P) receptor antagonist, for the treatment of generalized anxiety disorder.
55 Mizuta S et al. Catalytic decarboxylative fluorination for the synthesis of tri- and difluoromethyl arenes.
56 Morbelli S et al. Tissue specificity in fasting glucose utilization in slightly obese diabetic patients submitted to bariatric surgery.
57 Mosconi L et al. Amyloid and metabolic positron emission tomography imaging of cognitively normal adults with Alzheimer's parents.
58 Nordberg A et al. A European multicentre PETstudy of fibrillar amyloid in Alzheimer's disease.
59 Nuutila P. Brown adipose tissue thermogenesis in humans.
60 O'meara E et al. Alternative Imaging Modalities in Ischemic Heart Failure (AIMI-HF) IMAGE HF Project I-A: study protocol for a randomized controlled trial.
61 Orava J et al. Blunted metabolic responses to cold and insulin stimulation in brown adipose tissue of obese humans.
62 Oresic M et al. Prediction of non-alcholic fatty-liver disease and liver fat content by serum molecular lipids.
63 Paavilainen T et al. Diffusion tensor imaging and brain volumetry in Fabry disease patients.
64 Paterson I et al. Routine versus selective cardiac magnetic resonance in non-ischemic heart failure - OUTSMART-HF: study protocol for a randomized controlled trial (IMAGE-HF (heart failure) project 1-B).
65 Pepe A et al. Automatic statistical shape analysis of cerebral asymmetry in 3D T1-weighted magnetic resonance images at vertex-level: application to neuroleptic-naïve schizophrenia.
66 Pietiläinen KH et al. Agreement of bioelectrical impedance with dual-energy X-ray absorptiometry and MRI to estimate changes in body fat, skeletal muscle and visceral fat during a 12-month weight loss intervention.
67 Plein S et al. The year 2012 in the European Heart Journal-Cardiovascular Imaging. Part II.
68 Rinne P et al. Alpha-Melanocyte-stimulating hormone regulates vascular NO availability and protects against endothelial dysfunction.
69 Rissanen E et al. Adenosine A2A receptors in secondary progressive multiple sclerosis: a11C TJMSX brain PET study.
70 Rissanen TT et al. The bottleneck stent model for chronic myocardial ischemia and heart failure in pigs.
71 Roivainen A et al. Correlation of 18F-FDG PET/CT assessments with disease activity and markers of inflammation in patients with early rheumatoid arthritis following the initiation of combination therapy with triple oral antirheumatic drugs .
72 Roivainen A et al. Plasma pharmacokinetics, whole-body distribution metabolism, and radiation dosimetry of 68ga bombesin antagonist BAY 86-7548 in healthy men.
73 Roivainen A et al. Characterization of hepatic tumors using (11C)metomidate through positron emission tomography: comparison with (11C)acetate.
74 Rokka J et al. 19F/18F exchange synthesis for a novel [18F]S1P3-radiopharmaceutical.
75 Rudroff T et al. PET/CT imaging of age- and task-associated differences in muscle activity during fatiguing contractions.
76 Saunavaara V. Diffusion Tensor Imaging as a Diagnostic and Research Tool: A Study on Preterm Infants.
77 Schalin-Jäntti C et al. Planar scintigraphy with 123I/99mTc-Ssestamibi, 99mTc-sestamibi SPECT/CT, 11C-methionine PET/CT, or selective venous sampling before reopreration of primary hyperparathyroidism ?
78 Seppänen M. PET-tutkimus endokriinisten kasvainten diagnostiikassa ja hoidon seurannassa.
79 Setänen S et al. Predictive value of neonatal brain MRI on the neurodevelopmental outcome of preterm infants by 5 years of age.
80 Snellman A et al. Longitudinal amyloid imaging in mouse brain with 11C-PIB: comparison of APP23, Tg2576, and APPswe-PS1dE9 mouse models of Alzheimer disease.
81 Sperlich B et al. Squeezing the muscle: compression clothing and muscle metabolism during recovery from high intensity exercise.
82 Stenhagen ISR et al. [18F]fluorination of an arylboronic ester using (18F)selectfluor bis(triflate): application to 6-(18F)fluoro-L-DOPA.
83 Task Force Members et al. ESC guidelines on the management of stable coronary artery disease: the Task Force on the managements of stable coronary artery disease of the European Society of Cardiology.
84 Thieme S et al. High specific activity 6¹Cu via 64Zn(p,a)6¹Cu reaction at low proton energies.
85 Thomassen A et al. Hybrid CT angiography and quantitative 15O-water PET for assessment of coronary artery disease: comparison with quantitative coronary angiography.
86 Tunninen V et al. Comparison of five parathyroid scintigraphic protocols.
87 Tuominen L et al. Temperament, character and serotonin activity in the human brain:a positron emission tomography study based on a general population cohort.
88 Tuulari JJ et al. Weight loss after bariatric surgery reverses insulin-induced increases in brain glucose metabolism of the morbidly obese.
89 Uusitalo V et al. The association between coronary flow reserve and development of coronary calcifications: a follow-up study for 11 years in healthy young men.
90 Viitanen T et al. Lymphatic vessel function and lymphatic growth factor secretion after microvascular lymph node transfer in lymphedema patients.
91 Virta JJ et al. Midlife sleep characteristics associated with late life cognitive function.
92 Virta JJ et al. Midlife cardiovascular risk factors and late cognitive impairment.
93 Virtanen KA et al. Brown adipose tissue functions in humans.
94 Yim C-B et al. Synthesis and preclinical characterization of (64Cu)NODAGA-MAL-exendin-4 with a Nepsilon-maleoyl-L-lysyl-glycine linkage .
Julkaisutietokanta 12.9.2014 Publications Data Base 12.9.2014